Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elinzanetant for Vasomotor Symptoms in Postmenopausal Women
NCT05099159Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of elinzanetant in menopause, sponsored by Bayer. Started Oct 2021; status: completed.
02
Drugs
elinzanetant
03
Conditions
menopause
Beyond the preview
Go deeper on NCT05099159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05099159.